You are here: Industry Insights > EMA

News List

FDA and EMA offer updates on COVID-19 treatments and vaccines in development europeanpharmaceuticalreview
April 02, 2020
The FDA and EMA have announced which COVID-19 treatments and vaccines are currently in development, as well as how they are supporting clinical trials.
EMA warns consumers about falsified COVID-19 drugs from online pharmacies europeanpharmaceuticalreview
April 01, 2020
The European Medicines Agency (EMA) has advised consumers on how to recognise registered online pharmacies so they can avoid falsified medications.
CHMP backs eight new meds in virtual March meeting pharmatimes
March 31, 2020
Eight new medicines and six indication extensions have been recommended for approval at the European Medicines Agency’s (EMA) latests human medicines committee (CHMP).
EMA grants orphan drug designation to AlloVir’s Viralym-M pharmaceutical-business-review
March 31, 2020
AlloVir, a late-clinical stage allogeneic T-cell immunotherapy company, announced it has been granted Orphan Drug Designation from the European Medicines Agency (EMA) for Viralym-M (ALVR105).
Committee for Medicinal Products for Human Use (CHMP) meeting highlights europeanpharmaceuticalreview
March 31, 2020
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.
EMA advises continued use of hypertension drugs during COVID-19 pandemic europeanpharmaceuticalreview
March 31, 2020
The EMA has said that patients should continue to use angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), despite reports that these worsen COVID-19 infections.
EMA accepts Arvelle’s cenobamate MAA pharmatimes
March 30, 2020
Arvelle Therapeutics’ Marketing Authorisation Application (MAA) for cenobamate has been accepted by the European Medicines Agency (EMA).
Celsion’s GEN-1 Immunotherapy Receives Orphan Drug Designation from EMA americanpharmaceuticalreview
March 24, 2020
Celsion announced the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that GEN-1 be designated ...
“Harmonised approach” promoted for COVID-19 treatment clinical trials europeanpharmaceuticalreview
March 20, 2020
The EMA has urged that the research community prioritise large randomised controlled studies for COVID-19 treatments and vaccines.
EMA issues statement on ibuprofen reports relating to COVID-19 europeanpharmaceuticalreview
March 20, 2020
The EMA has announced that reports of NSAIDs like ibuprofen making the COVID-19 coronavirus worse have no scientific basis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 31 32 Next page